Correction of vaccine effectiveness derived from test-negative case–control studies
Abstract Background Determining the vaccine effectiveness (VE) is an important part of studying every new vaccine. Test-negative case–control (TNCC) studies have recently been used to determine the VE. However, the estimated VE derived from a TNCC design depends on the test sensitivity and specifici...
Main Author: | Farrokh Habibzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-023-01962-0 |
Similar Items
-
A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19
by: Juan Jeferson Vilca-Alosilla, et al.
Published: (2023-04-01) -
Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study
by: Anton Barchuk, et al.
Published: (2022-09-01) -
On the importance of early testing even when imperfect in a pandemic such as COVID-19
by: Neal D. Goldstein, et al.
Published: (2020-11-01) -
Sensibility and Specificity of the VitaPCR™ SARS-CoV-2 Assay for the Rapid Diagnosis of COVID-19 in Older Adults in the Emergency Department
by: Francesco Piacenza, et al.
Published: (2023-01-01) -
SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study
by: Ireri Thirión-Romero, et al.
Published: (2023-11-01)